These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18050249)

  • 1. Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome.
    Todd I; Radford PM; Ziegler-Heitbrock L; Ghaemmaghami AM; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Dec; 56(12):4182-8. PubMed ID: 18050249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective expansion of the CD14(+)/CD16(bright) subpopulation of circulating monocytes in patients with hemophagocytic syndrome.
    Takeyama N; Yabuki T; Kumagai T; Takagi S; Takamoto S; Noguchi H
    Ann Hematol; 2007 Nov; 86(11):787-92. PubMed ID: 17619880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
    Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF
    Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
    Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
    Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma.
    Dayyani F; Joeinig A; Ziegler-Heitbrock L; Schmidmaier R; Straka C; Emmerich B; Meinhardt G
    J Leukoc Biol; 2004 Feb; 75(2):207-13. PubMed ID: 14576364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
    Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
    J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.
    Huggins ML; Radford PM; McIntosh RS; Bainbridge SE; Dickinson P; Draper-Morgan KA; Tighe PJ; Powell RJ; Todd I
    Arthritis Rheum; 2004 Aug; 50(8):2651-9. PubMed ID: 15334481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial DNA and endothelial damage in haemodialysis patients.
    Merino A; Nogueras S; García-Maceira T; Rodríguez M; Martin-Malo A; Ramirez R; Carracedo J; Aljama P
    Nephrol Dial Transplant; 2008 Nov; 23(11):3635-42. PubMed ID: 18511607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
    Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
    Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?
    Timmerman KL; Flynn MG; Coen PM; Markofski MM; Pence BD
    J Leukoc Biol; 2008 Nov; 84(5):1271-8. PubMed ID: 18664531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages.
    Kramer PR; Kramer SF; Guan G
    Arthritis Rheum; 2004 Jun; 50(6):1967-75. PubMed ID: 15188374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease.
    Sen A; Chowdhury IH; Mukhopadhyay D; Paine SK; Mukherjee A; Mondal LK; Chatterjee M; Bhattacharya B
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6940-8. PubMed ID: 21791592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor response of CD14+/CD16+ monocyte subpopulation.
    Szaflarska A; Baj-Krzyworzeka M; Siedlar M; Weglarczyk K; Ruggiero I; Hajto B; Zembala M
    Exp Hematol; 2004 Aug; 32(8):748-55. PubMed ID: 15308326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
    Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
    Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.
    Dodé C; Papo T; Fieschi C; Pêcheux C; Dion E; Picard F; Godeau P; Bienvenu J; Piette JC; Delpech M; Grateau G
    Arthritis Rheum; 2000 Jul; 43(7):1535-42. PubMed ID: 10902757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 in combination with M-CSF and IL-4 contributes to development of the rare population of CD14+CD16++ cells derived from human monocytes.
    Li G; Hangoc G; Broxmeyer HE
    Biochem Biophys Res Commun; 2004 Sep; 322(2):637-43. PubMed ID: 15325277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.